MIR4257: A Drug Target / Disease Biomarker (G100422997)
MIR4257: A Drug Target / Disease Biomarker
MIR4257 is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the Mir gene family, which encodes for a family of transmembrane proteins that play a role in the regulation of ion channels and the transport of various molecules across cell membranes.
One of the unique features of MIR4257 is its ability to interact with multiple intracellular signaling pathways, including TGF-β, NF-kappa-B, and PI3K. This makes it an attractive target for researchers looking for new potential drug treatments.
MIR4257 has also been shown to play a role in the regulation of pain perception and neuroinflammation. Studies have shown that MIR4257 is involved in the neurotransmitter release that occurs following pain exposure, and that it may also contribute to the production of pro-inflammatory cytokines.
In addition to its potential role in pain and neuroinflammation, MIR4257 has also been shown to be involved in the regulation of cell survival and metabolism. Studies have shown that MIR4257 can interact with the protein p53, which is a well-known regulator of DNA damage repair, and that this interaction may contribute to the regulation of cell survival.
MIR4257 is also a good candidate for a biomarker in disease diagnosis and monitoring. Its expression has been shown to be affected by a number of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. This makes it a potential candidate for use as a diagnostic or monitoring tool in these diseases.
In conclusion, MIR4257 is a protein that has the potential to be a drug target or biomarker. Its ability to interact with multiple intracellular signaling pathways and its involvement in the regulation of pain perception, neuroinflammation, cell survival, and metabolism make it an attractive target for research in these areas. Further studies are needed to fully understand the role of MIR4257 in these processes and its potential as a drug or biomarker.
Protein Name: MicroRNA 4257
The "MIR4257 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR4257 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
MIR4258 | MIR4259 | MIR4260 | MIR4261 | MIR4262 | MIR4263 | MIR4264 | MIR4265 | MIR4266 | MIR4267 | MIR4268 | MIR4269 | MIR4270 | MIR4271 | MIR4272 | MIR4273 | MIR4274 | MIR4275 | MIR4276 | MIR4277 | MIR4278 | MIR4279 | MIR4280 | MIR4281 | MIR4282 | MIR4283-1 | MIR4283-2 | MIR4284 | MIR4285 | MIR4286 | MIR4287 | MIR4288 | MIR4289 | MIR429 | MIR4290 | MIR4291 | MIR4292 | MIR4293 | MIR4294 | MIR4295 | MIR4296 | MIR4297 | MIR4298 | MIR4299 | MIR4300 | MIR4300HG | MIR4301 | MIR4302 | MIR4303 | MIR4304 | MIR4305 | MIR4306 | MIR4307 | MIR4308 | MIR4309 | MIR431 | MIR4310 | MIR4311 | MIR4312 | MIR4313 | MIR4314 | MIR4315-1 | MIR4315-2 | MIR4316 | MIR4317 | MIR4318 | MIR4319 | MIR432 | MIR4320 | MIR4321 | MIR4322 | MIR4323 | MIR4324 | MIR4325 | MIR4326 | MIR4327 | MIR4328 | MIR4329 | MIR433 | MIR4330 | MIR4418 | MIR4420 | MIR4423 | MIR4425 | MIR4427 | MIR4428 | MIR4429 | MIR4430 | MIR4431 | MIR4432 | MIR4432HG | MIR4433A | MIR4433B | MIR4435-1 | MIR4435-2 | MIR4435-2HG | MIR4436A | MIR4436B1 | MIR4436B2 | MIR4437
